For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() The Hartford Insurance Group Inc.HIG US · Financials · USD Current price$135.58as of Nov 20, 2026 Summary
Analyst consensusStrong Buy 2Buy 5Hold 1721 analysts 3-year price (USD)Factor profileMulti-factor score 72 / 100 Market data
Business descriptionThe Hartford is a diversified U.S. P&C and group benefits insurer with four engines: Business Insurance (Small Business, Middle & Large, Global Specialty), Personal Insurance (auto/home, AARP), Employee Benefits and Hartford Funds. Competitive moatScale and underwriting expertise in small commercial (Small Business underlying CR 85.2%, improving 4.6 pts), specialty lines and workers' comp, plus the AARP personal lines franchise. Favourable workers' comp reserve development (USD 57M in Q3) signals conservative reserving. Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Nov 18, 2026
Current price: $135.58 · Nov 20, 2026· USD
CFRA Ratingbuy12-Mo Target: USD 158.00
TBI Multi Score72
Theme Exposure
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: HIGBusiness description
The Hartford is a diversified U.S. P&C and group benefits insurer with four engines: Business Insurance (Small Business, Middle & Large, Global Specialty), Personal Insurance (auto/home, AARP), Employee Benefits and Hartford Funds.
Competitive moat
Scale and underwriting expertise in small commercial (Small Business underlying CR 85.2%, improving 4.6 pts), specialty lines and workers' comp, plus the AARP personal lines franchise. Favourable workers' comp reserve development (USD 57M in Q3) signals conservative reserving.
Recent developments
- Q3 2026 (11/17/2026): Core EPS USD 3.50 (vs 3.59), in line with CFRA and USD 0.33 above consensus; quality of beat flagged - LP/alternative income surged to USD 156M (10.2% yield vs USD 91M), lumpy. NII USD 850M (+13%); ex-LP NII +5%.
- A&E cover commuted: USD 497M pre-tax gain on commutation of the asbestos & environmental ADC with National Indemnity (Berkshire), USD 1.12B proceeds; excluded from core.
- Business Insurance: written premiums USD 3,772M (+6%); Middle & Large underlying CR deteriorated to 99.5 (from 91.4; Q2 95.3) on non-CAT property and WC loss ratios.
- Personal Insurance: core earnings USD 105M (-27%); written premiums -4% (auto -8%); renewal pricing moderating (auto 5.1%, home 7.9%).
- Employee Benefits: core earnings USD 120M (-19%); loss ratio +4.8 pts to 74.9, group disability incidence rising.
- Capital & governance: USD 638M returned in Q3; dividend +12%; CEO Christopher Swift to become Executive Chair on 03/01/2027, Mo Tooker succeeds as CEO.
Investment risks / red flags
- Middle & Large Business margin deterioration (two consecutive quarters)
- Disability claim incidence trend in Employee Benefits
- Reliance on lumpy LP income for EPS beats
- Leadership transition (2027), deteriorating claim trends, credit/equity market drawdown
Market Data
Source: mkts.io · Nov 20, 2026, 12:01 UTC
Key Metrics
P/E (TTM)9.07
P/E (Fwd)9.96
Dividend1.98%
Beta0.47
52W High$146.07
52W Low$120.42
Analyst Consensus
2
5
17
Strong Buy2Buy5Hold1721 analysts
Consensus Target$145.76
+7.5% upside
Calendar Events
Next EarningsJan 28, 2027
Ex-DividendDec 1, 2026
Dividend DateJan 5, 2027
Financials
Revenue$29.59B
Rev Growth3.90%
Earnings Growth28.00%
Gross Margin38.57%
Op Margin19.01%
Profit Margin15.57%
EBITDA$5.96B
ROA4.08%
ROE23.25%
Rev/Share$107.80
Total Cash$4.51B
Total Debt$4.37B
D/E Ratio23.16
Free Cash Flow$7.38B
Op Cash Flow$6.99B
Current Ratio1.67
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 3.22 | $7.33B |
| +1q | 3.42 | $7.49B |
| 0y | 13.24 | $28.86B |
| +1y | 13.61 | $30.32B |
Earnings
Quarterly EPS
4Q2025
Est: 3.224.06Beat
1Q2026
Est: 3.393.09Miss
2Q2026
Est: 3.143.42Beat
3Q2026
Est: 3.173.50Beat
Annual
2022
Rev $22.36BEarn $1.79B
2023
Rev $24.53BEarn $2.48B
2024
Rev $26.54BEarn $3.09B
2025
Rev $28.37BEarn $3.81B
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Nov 12, 2026 | Mizuho | main | Neutral |
| Nov 11, 2026 | Wells Fargo | down | Equal-Weight |
| Nov 2, 2026 | Cantor Fitzgerald | main | Overweight |
| Oct 12, 2026 | Keefe, Bruyette & Woods | main | Market Perform |
| Oct 12, 2026 | Wells Fargo | main | Overweight |
| Oct 12, 2026 | Truist Securities | init | Hold |
